Global Cord Blood
CORBF
$1.25
Share price
0.00%
Change (1 day)
-58.19%
Change (1 year)
Categories
Global Cord Blood (CORBF) - P/B ratio
P/B ratio as of April 2024 : 0.2175
According to Global Cord Blood's latest financial reports the company has a price-to-book ratio of 0.2175.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Global Cord Blood - P/B ratio (from 2007 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 0.5198 | -23.32% |
| 2021-12-31 | 0.6779 | -1.69% |
| 2020-12-31 | 0.6895 | -38.39% |
| 2019-12-31 | 1.12 | -30.58% |
| 2018-12-31 | 1.61 | -32.83% |
| 2017-12-31 | 2.40 | 36.94% |
| 2016-12-31 | 1.75 | -1.24% |
| 2015-12-31 | 1.77 | 30.1% |
| 2014-12-31 | 1.36 | 8.61% |
| 2013-12-31 | 1.26 | 27.25% |
| 2012-12-31 | 0.9872 | -7.64% |
| 2011-12-31 | 1.07 | -43.2% |
| 2010-12-31 | 1.88 | -49.26% |
| 2009-12-31 | 3.71 | 98.33% |
| 2008-12-31 | 1.87 | 29.82% |
| 2007-12-31 | 1.44 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | 4.39 | 1,920.66% | 🇺🇸 USA |
 National Healthcare
NHC | 1.54 | 607.40% | 🇺🇸 USA |
 NeoGenomics
NEO | 1.92 | 784.46% | 🇺🇸 USA |
 Cryo-Cell CCEL | -6.21 | -2,954.75% | 🇺🇸 USA |